- Home
- PGEN vs TR Comparison
PGEN vs TR Comparison
Compare PGEN & TR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PGEN | TR |
|---|---|---|
| Founded | 1998 | 1896 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.8B |
| IPO Year | 2013 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PGEN | TR |
|---|---|---|
| Price | $7.02 | $36.87 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $13.65 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 150.4K |
| Earning Date | 11-04-2026 | 10-21-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | N/A | ★ 12.30 |
| EPS | 0.03 | ★ 0.41 |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $2,335.22 | N/A |
| Revenue Next Year | $85.34 | N/A |
| P/E Ratio | $223.17 | ★ $89.44 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.04 | $33.95 |
| 52 Week High | $8.98 | $45.06 |
Technical Indicators
Market Signals| Indicator | PGEN | TR |
|---|---|---|
| Relative Strength Index (RSI) | 50.05 | 50.29 |
| Support Level | $6.57 | $36.80 |
| Resistance Level | $7.44 | $40.09 |
| Average True Range (ATR) | 0.42 | 1.05 |
| MACD | -0.03 | 0.00 |
| Stochastic Oscillator | 55.14 | 56.36 |
Price Performance
Historical ComparisonAbout PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
About TR Tootsie Roll Industries Inc.
Tootsie Roll Industries Inc manufactures and sells confectionery products. Notable varieties include Tootsie Roll and Tootsie Pops, Charms, Blow-Pops, Dots, Junior Mints, Sugar Daddy and Sugar Babies, Andes, Dubble Bubble, Razzles among others. The company sells its products to wholesale distributors and directly to retail stores. Geographically, it generates a majority of its revenue from the United States and rest from Canada, Mexico and other regions.